With No Lysine Kinase 3 (WNK3); A Target Enabling Package od Pinkas, D

Kolejni autorzy: “…Pinkas, D…”

With no lysine kinase 3 (WNK3); A Target Enabling Package od Pinkas, D

Kolejni autorzy: “…Pinkas, D…”

Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors od Suebsuwong, C, Pinkas, D, Ray, S, Bufton, J, Dai, B, Bullock, A, Degterev, A, Cuny, G

2-amino-2, 3-dihydro-1H-indene-5-carboxamide-based discoidin domain receptors 1 (DDR1) inhibitors: design, synthesis, and in vivo anti-pancreatic cancer efficacy od Zhu, D, Huang, H, Pinkas, D, Luo, J, Ganguly, D, Fox, A, Arner, E, Xiang, Q, Tu, Z, Bullock, A, Brekken, R, Ding, K, Lu, X

BTB domain mutations perturbing KCTD15 oligomerisation cause a distinctive frontonasal dysplasia syndrome od Miller, K, Cruz Walma, D, Pinkas, D, Tooze, R, Bufton, J, Richardson, W, Manning, C, Hunt, A, Cros, J, McGowan, S, Twigg, S, Chalk, R, Staunton, D, Johnson, D, Wilkie, A, Bullock, A

The DUF1669 domain of FAM83 family proteins anchor casein kinase 1 isoforms od Fulcher, L, Bozatzi, P, Tachie-Menson, T, Wu, K, Cummins, T, Bufton, J, Pinkas, D, Dunbar, K, Shrestha, S, Wood, N, Weidlich, S, Macartney, T, Varghese, J, Gourlay, R, Campbell, D, Dingwell, K, Smith, J, Bullock, A, Sapkota, G

Design, synthesis, and biological evaluation of 3-(imidazo[1,2-a]pyrazin-3-ylethynyl)-4-isopropyl-N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)benzamide as a dua... od Wang, Z, Zhang, Y, Pinkas, D, Fox, A, Luo, J, Huang, H, Cui, S, Xiang, Q, Xu, T, Xun, Q, Zhu, D, Tu, Z, Ren, X, Brekken, R, Bullock, A, Liang, G, Ding, K, Lu, X

With No Lysine Kinase 3 (WNK3); A Target Enabling Package od Bullock, A

Kolejni autorzy: “…Pinkas, D…”